Recursion Pharmaceuticals Inc - Class A — Bilancio Trimestrale (NASDAQ:RXRX) | MetaTrader

Apri il grafico completo

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

Notizie

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors

Citeline espande la partnership con Recursion per gli studi clinici

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

Le azioni di Recursion Pharmaceuticals toccano il minimo a $2,98

Bitcoin Skids, $14 Bil In Options Due; Cathie Wood Raises Cash

ARK di Cathie Wood vende azioni Meta e Nvidia, acquista Tempus AI

Recursion nomina Vicki Goodman come chief medical officer

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Rose the dog might have just heralded the age of programmable medicine — and here are the stocks that benefit

Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

PacBio nomina Gibson, co-fondatore di Recursion, nel consiglio

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down